Home LiteratureArticle Details
PMID: 551291 Published · ppublish English Journal Article

Biological degradation of TCDD in rats.

Nature ·Vol. 281 ·No. 5733 ·1979-10-25 ·Pages 706-7

Poiger H, Schlatter C

Abstract

Apart from its high toxicity, the chemical stability and persistence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the environment bring about additional hazards. However, until now there has been no evidence for degradation of this dioxin in biological systems, and it is considered unusual that a compound which is insusceptible to biological attack should be so extremely toxic. In in vitro studies with microsomal preparation from mouse, rat and rabbit liver, as well as in vivo, no metabolite of TCDD has been detected by several workers. Recent data, showing a lower toxicity of TCDD in rats after stimulation of the hepatic mixed-function oxidase, suggested possible metabolic transformation of this compound. In the present study, we used tritiated TCDD to search for metabolites in the bile of rats and found marked changes in lipophilicity and mobility in TLC of the excreted radioactivity. Treatment with diazomethane yielded at least two new compounds. These observations hinted at the formation of phenolic hydroxyl groups in the dioxin molecule.

MeSH Terms
Animals Bile/metabolism Biotransformation Dioxins/metabolism Female Liver/metabolism Polychlorinated Dibenzodioxins/metabolism Rats Solubility
Chemicals
Dioxins Polychlorinated Dibenzodioxins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Poiger H
Schlatter C
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
Published
1979-10-25
Pages
706-7
Language
English
Region
England
NLM ID
0410462
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com